0 likes | 4 Vues
AI-powered pharmacovigilance represents a fundamental shift in how pharmaceutical companies manage drug safety and competitive positioning. Companies that recognize this shift early gain strategic advantages. Companies that delay face competitive disadvantages and regulatory risks. The choice is simple: Transform your pharmacovigilance capabilities now or explain to stakeholders later why you didnu2019t. Every day you delay is another day your competitors get ahead in the most critical aspect of pharmaceutical operations: patient safety.
E N D